UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

Phase 1

Suspended

Conditions: Congenital Adrenal Hyperplasia

Interventions: Drug: Abiraterone acetate

First Posted Date: 2015-10-14

Last Posted Date: 2024-03-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 36

Registration Number: NCT02574910

Locations: 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Medical Center, Dallas, Texas, United States
🇺🇸
National Institutes of Health, Bethesda, Maryland, United States

and more 1 locations

Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery

Not Applicable

Completed

Conditions: Incipient Cataract
Senile Nuclear Sclerosis

Interventions: Procedure: Traditional manual phacoemulsification
Procedure: Laser-assisted cataract surgery.

First Posted Date: 2015-09-25

Last Posted Date: 2020-05-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 148

Registration Number: NCT02561104

Locations: 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination

Not Applicable

Completed

Conditions: Human Papillomavirus Vaccines

Interventions: Behavioral: Project Voice

First Posted Date: 2015-09-02

Last Posted Date: 2020-05-18

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 737

Registration Number: NCT02537756

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

Not Applicable

Terminated

Conditions: Human Papillomavirus Vaccines

Interventions: Behavioral: HPV Informational Video
Behavioral: Project Voice

First Posted Date: 2015-08-31

Last Posted Date: 2024-01-30

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 22

Registration Number: NCT02535845

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

Phase 2

Terminated

Conditions: Hepatocellular Carcinoma

Interventions: Drug: LEE011
Procedure: Chemoembolization

First Posted Date: 2015-08-14

Last Posted Date: 2021-02-01

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 5

Registration Number: NCT02524119

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Chronotropic Incompetence in Patients With HFpEF

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Static Handgrip
Drug: Dexmedetomidine
Drug: Glycopyrrolate
Drug: Isoproterenol

First Posted Date: 2015-08-14

Last Posted Date: 2020-08-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 40

Registration Number: NCT02524145

Locations: 🇺🇸
The Institute for Exercise and Environmental Medicine, Dallas, Texas, United States

ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: ARQ-761
Drug: Gemcitabine
Drug: nab-paclitaxel

First Posted Date: 2015-08-03

Last Posted Date: 2022-06-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 17

Registration Number: NCT02514031

Locations: 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma

Phase 2

Terminated

Conditions: ALK-positive Non-small Cell Lung Cancer

Interventions: Drug: Ceritinib
Radiation: Stereotactic ablative body radiation

First Posted Date: 2015-07-31

Last Posted Date: 2023-02-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 14

Registration Number: NCT02513667

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers

Not Applicable

Completed

Conditions: Foot Ulcer, Diabetic

Interventions: Device: Transcutaneous O2 device

First Posted Date: 2015-07-17

Last Posted Date: 2023-07-24

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 23

Registration Number: NCT02501538

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients

Not Applicable

Completed

Conditions: Migraine Headache

Interventions: Drug: Propofol

First Posted Date: 2015-06-30

Last Posted Date: 2024-03-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 40

Registration Number: NCT02485418

Locations: 🇺🇸
Children's Health Children's Medical Center Dallas, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy